Food and Drug Administration (FDA) Director General Rolando Enrique Domingo said Chinese drug firm Sinovac Biotech has applied for an amendment of its emergency use authorization (EUA) for its Covid-19 vaccine to be used on children aged 3 to 17.
"The Sinovac, just this afternoon (July 6), applied for an amendment of their EUA to include children. In this case, children from three to 17 years old," Domingo said in a meeting with President Rodrigo Duterte on Monday.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.